News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Sep 8, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Sep 6, 2023 Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference Sep 5, 2023 INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC Aug 4, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Aug 3, 2023 Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update Jul 20, 2023 Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023 Jul 7, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jun 7, 2023 Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference Jun 6, 2023 Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 22, 2023 Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference Show 5102550100 per page«123456789…68» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download